Various investors, including SoftBank Vision, Apollo, OrbiMed, Tencent, and RA Capital Management, are funding oncology research and innovation. Collectively, investments in the sector exceed $17 billion,...
The company has confirmed that, as a result of its commitment to R&D in oncology, it has achieved a success rate of 37% in its research, compared...